Intravenous Infusions Plc

GHSE:IIL Stock Report

Market Cap: GH₵13.7m

Intravenous Infusions Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Moukhtar Soalihu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.1yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure7.8yrs

Recent management updates

Recent updates


CEO

Moukhtar Soalihu (53 yo)

4.1yrs

Tenure

Mr. Moukhtar M. Soalihu serves as Managing Director at Intravenous Infusions Plc since September 2020 and serves as its Executive Director. He served as Acting Managing Director of Intravenous Infusions Pl...


Leadership Team

NamePositionTenureCompensationOwnership
Moukhtar Soalihu
MD & Executive Director4.1yrsno datano data
Eugenia Bulley
General Manager of Finance & Administration3.3yrsno datano data
Kenneth Awude
General Manager of Technical & Operations3.3yrsno datano data
Isaac Nsiah-Afriyie
General Manager of Marketingless than a yearno datano data
Solomon Puplampu
Head Of Engineeringno datano datano data
Samuel Marfo
Head of Internal Auditno datano datano data

3.3yrs

Average Tenure

53yo

Average Age

Experienced Management: IIL's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Moukhtar Soalihu
MD & Executive Director4.1yrsno datano data
Isaac Osei
Non-Executive Chairman25.8yrsno datano data
Leon Appenteng
Non-Executive Director35.8yrsno datano data
Samuel Kwadjo Appenteng
Non-Executive Director35.8yrsno datano data
Gladys Amponsah
Independent Non-Executive Director10.3yrsno datano data
Williams Atulik
Independent Non-Executive Director5.4yrsno datano data
Emmanuel Blankson
Non-Executive Director4.7yrsno datano data
Nana Kwame Kyeretwie
Non-Executive Director1.3yrsno datano data

7.8yrs

Average Tenure

62yo

Average Age

Experienced Board: IIL's board of directors are considered experienced (7.8 years average tenure).